These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5360059)

  • 1. The effect of some monoamine oxidase inhibitors on gluconeogenesis.
    Triner L; Verosky M; Papayoanou J; Nahas GG
    Life Sci; 1969 Dec; 8(23):1281-90. PubMed ID: 5360059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective inhibition by pargyline and phenelzine of oxidation of biogenic amines in vivo].
    Romanova LA; Gorkin VZ
    Farmakol Toksikol; 1969; 32(6):667-9. PubMed ID: 5381595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition by monoamine oxidase inhibitors of substrate induction of liver tryptophan pyrrolase and increase in brain serotonin].
    Samsonova ML; Oksenkrug GF
    Vopr Med Khim; 1972; 18(2):198-202. PubMed ID: 4679586
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of monoamine oxidase inhibitors on formation of morphine glucuronide.
    Yeh SY; Mitchell CL
    Biochem Pharmacol; 1972 Feb; 21(4):571-8. PubMed ID: 5014513
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of hepatic gluconeogenesis by phenethylhydrazine (phenelzine).
    Kleineke J; Peters H; Söling HD
    Biochem Pharmacol; 1979 Apr; 28(8):1379-89. PubMed ID: 220986
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors and liver metabolism: studies with isolated rat hepatocytes.
    Carr FP; Smith SA; Pogson CI
    Biochem Pharmacol; 1980 Apr; 29(8):1103-8. PubMed ID: 7387727
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
    Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I
    Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible role of hydrazine group in hypoglycemia associated with the use of certain monoamine-oxidase inhibitors (MAOI's).
    Potter WZ; Zaharko DS; Beck LV
    Diabetes; 1969 Aug; 18(8):538-41. PubMed ID: 5808748
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of insulin release by substrates and inhibitors of monoamine oxidase.
    Aleyassine H; Lee SH
    Am J Physiol; 1972 Mar; 222(3):565-9. PubMed ID: 5022664
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamineoxidase inhibition and insulin sensitivity.
    Adnitt PI
    J Endocrinol; 1968 Nov; 42(3):417-23. PubMed ID: 5250314
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 15. N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.
    McKenna KF; Baker GB; Coutts RT
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):478-82. PubMed ID: 1881457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressants and liver tryptophan pyrrolase activity.
    Samsonova ML; Lapin IP
    Biochem Pharmacol; 1973 Jun; 22(12):1499-507. PubMed ID: 4732526
    [No Abstract]   [Full Text] [Related]  

  • 18. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH; Tashjian AH
    Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.